Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
8.56
+1.06 (14.13%)
At close: May 22, 2025

RAJAF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-8.80-8.80-0.62-8.13-133.88
Debt / EBITDA Ratio
1.931.93-65.3732.33
Debt / FCF Ratio
5.905.90---
Asset Turnover
0.320.320.02--
Quick Ratio
0.050.050.010.160.00
Current Ratio
0.110.110.200.390.39
Return on Assets (ROA)
5.10%5.10%-9.67%-2.45%-
Return on Capital (ROIC)
110.62%110.62%-32.28%-4.07%-
Return on Capital Employed (ROCE)
45.70%45.70%--3.20%
Buyback Yield / Dilution
-11.12%-6.42%-4.42%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.